Literature DB >> 28844546

Etiological Classification of Stroke in Patients with Chagas Disease Using TOAST, Causative Classification System TOAST, and ASCOD Phenotyping.

Rodrigo de Paiva Bezerra1, Maramélia Araújo de Miranda Alves2, Adriana Bastos Conforto2, Daniela Laranja Gomes Rodrigues2, Gisele Sampaio Silva2.   

Abstract

BACKGROUND: Cardioembolism is considered a major pathophysiological mechanism in patients with ischemic stroke (IS) and Chagas disease (CD). However, a previous study reported that other stroke subtypes are present in more than 40% of CD patients according to the TOAST classification. Therefore, the aim of our study was to evaluate the etiologic classification of stroke in patients with CD using the Causative Classification System (CCS), the ASCOD, and the TOAST classifications in a prospective cohort of patients.
METHODS: Patients evaluated in our outpatient clinic from 2012 to 2015 with IS and CD were included and underwent full investigation for stroke etiology. TOAST, CCS TOAST, and the ASCOD classifications were compared.
FINDINGS: We Included 32 patients (18 men; mean age 62.7 +/-10.1 years). A total of 93.8% had at least 1 vascular risk factor; the most frequent was hypertension (87.5%). According to TOAST, we defined 87.5% as having cardioembolic stroke, being 9.4% as large-artery atherosclerotic (LAA) and 3.1% as undetermined cause. Using the CCS TOAST, 62.5% were classified as cardioaortic embolism evident and 15.6% as possible, 6.3% as small artery occlusion evident and 3.1% as probable, and 12.5% as LAA evident. When ASCOD phenotyping was applied, atherosclerosis was present in 50.1% of patients (A1 = 6.3%, A3 = 43.8%), cardiac pathology in 84.4% (C1 = 62.5%, C2 = 15.6%, C3 = 6.3%), and small-vessel disease in 66% (S1 = 9.4%, S2 = 3.1%, S3 = 3.1%).
FINDINGS: In conclusion, the use of the CCS and the ASCOD phenotyping in patients with CD confirmed a high frequency of cardioembolic IS but also showed that other etiologies are prevalent, such as large-artery atherosclerosis and small-vessel occlusion.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chagas; Ischemic; embolism; stroke

Mesh:

Year:  2017        PMID: 28844546     DOI: 10.1016/j.jstrokecerebrovasdis.2017.07.007

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  Carotid Intraplaque-Hemorrhage Volume and Its Association with Cerebrovascular Events.

Authors:  L Saba; G Micheletti; W Brinjikji; P Garofalo; R Montisci; A Balestrieri; J S Suri; J K DeMarco; G Lanzino; R Sanfilippo
Journal:  AJNR Am J Neuroradiol       Date:  2019-09-26       Impact factor: 3.825

2.  MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.

Authors:  Lamia M'barek; Salma Sakka; Fatma Meghdiche; Dhaker Turki; Khadija Maalla; Mariem Dammak; Choumous Kallel; Chokri Mhiri
Journal:  Metab Brain Dis       Date:  2021-01-05       Impact factor: 3.584

Review 3.  Management of Cardiovascular Disease in Patients With COVID-19 and Chronic Chagas Disease: Implications to Prevent a Scourge Still Larger.

Authors:  Reinaldo Bulgarelli Bestetti; Edimar Alcides Bocchi; Renato Bestetti; Victor Sarli Issa; Rosemary Aparecida Furlan-Daniel; Marcelo Arruda Nakazone
Journal:  Front Med (Lausanne)       Date:  2022-06-29

4.  Neuroemergencies in South America: How to Fill in the Gaps?

Authors:  Gisele Sampaio Silva; Nelson J Maldonado; Jorge H Mejia-Mantilla; Santiago Ortega-Gutierrez; Jan Claassen; Panayiotis Varelas; Jose I Suarez
Journal:  Neurocrit Care       Date:  2019-12       Impact factor: 3.210

5.  Associations of plasma LP(a), Hcy and D-D levels with the subtype of ischemic cerebrovascular disease.

Authors:  Yong Tang; Deqin Geng
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.